TGFB1 and cancer: TGF-B is a well-known inducer of epithelial-mesenchymal transition (EMT) [4], a process that alters cytoskeletal structure and cellular motility, often enhancing the metastatic potential of cancer cells, and driving a more aggressive phenotype [9, 10] with nuclear abnormalities and chromatin remodelling [11].